ALI MEA60: A porous thin-film microelectrode array for air-liquid interface electrophysiology of 3D excitable tissues
En palabras de los autores
Objective: Conventional microelectrode arrays (MEAs) are suboptimal for long-term electrophysiology of three-dimensional (3D) excitable tissues, as limited oxygenation, nutrient diffusion, and tissue-electrode coupling compromise recording stability. Air-liquid interface (ALI) culture mitigates these constraints, but existing ALI MEA platforms are limited in channel count, flexibility, and compatibility with commercial multichannel acquisition systems. We developed and comprehensively characterized a next-generation ALI MEA for standardized, long-term recordings across multiple 3D excitable tissue models. Approach: The novel ALI MEA60 is composed of a porous polyimide membrane that integrates an array of 60 thin film microelectrodes (59 recording, one reference) and a basal perfusion chamber with Luer-lock connectors for controlled medium exchange and pharmacological wash-in/wash-out. It is compatible with the MEA2100-Mini data acquisition system (Multi Channel Systems). We characterized electrode impedance and noise across 41 ALI MEA60 devices, assessed 60-day stability with human iPSC-derived neural spheroids (N = 7 MEAs, 121 recordings) using a standardized longitudinal framework and linear mixed-effects models, and evaluated its versatility through pharmacological assays and recordings from human neural spheroids, brain organoids, ex vivo brain slices, and cardiac organoids. Main results: The platform showed reproducible electrical performance (median impedance 56 kOhms; at 1 kHz) and low noise (approx. 5uV Root Mean Square (RMS) in saline, 10-20 uV in medium), resolving spikes and local field potentials simultaneously. Recording remained stable for at least 60 days, with a stable noise floor and ~85% persistence of initial functional channels. Neural spheroids reproduced the standard qualitative signatures to gabazine, 4-aminopyridine (4-AP), and 6-Cyano-7-nitroquinoxaline-2,3-dione/D-2-amino-5-phosphonovalerate (CNQX/D-AP5), while cardiac organoids showed the expected beta-adrenergic response to isoproterenol. The ALI MEA60 can similarly record signals from human brain slices and organoids without hardware modification. Significance: The ALI MEA60 combines ALI culture, chronic recording stability, standardized pharmacological testing and cross-tissue compatibility in a single ready-to-use platform. It also establishes a reproducible framework for benchmarking long-term electrophysiological performance, thereby supporting disease modelling, drug discovery, organ-on-chip technologies and future chronic 3D electrophysiology systems. Keywords: microelectrode array (MEA); air-liquid interface (ALI); 3D excitable tissues; neural spheroids; cardiac organoids; chronic electrophysiology.
Apareció: jueves, 19 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.